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Abstract
This systematic review investigated thirteen primary and secondary research studies from the
past 20 years to determine the effects of intermittent fasting on chronic disease in adults
through evaluation of biological markers pertaining to inflammation, oxidative stress, and the
cardiovascular system. The dependent variables examined included heart rate, blood
pressure, and cholesterol levels for cardiovascular risk; leptin and TNF- for inflammatory
risk; and F2-Isoprostanes and free radicals for oxidative stress biomarkers. The reviewed
studies found that there was a decrease in resting heart rate, systolic and diastolic blood
pressure, blood LDL and total cholesterol levels, inflammatory cells, like leptin, TNF-, and
insulin, and oxidative stress (isoprostanes and free radicals); and an increase in HDL
cholesterol levels and insulin sensitivity in human and animal subjects engaged in various
forms of intermittent fasting. The reviewed effects in both human and animal trials point to
beneficial health effects of intermittent fasting in preventing and resisting chronic disease
risk factors. In the short-term, it can be implicated that intermittent fasting could be
successful in preventing chronic disease from a holistic perspective. This review is limited
due to its narrow examination of only thirteen studies, minimal intervention time, and small
population size for tested subjects.

Keywords: intermittent fasting, intermittent energy restriction, caloric restriction, chronic
disease, inflammation, oxidative stress, cardiovascular system
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The Effects of Intermittent Fasting on Chronic Disease in Adults:
A Systematic Review
Chronic diseases combined, which is a general term for any disease that lasts for three
or more months and is generally incurable and ongoing, were recently labeled as a leading
cause of death in the United States (Buttorff, Ruder, and Bauman, 2017). These detrimental
diseases included diabetes, cardiovascular disease, hypertension, stroke, metabolic diseases,
pulmonary conditions, and even cancer (Roberts and Barnard, 2005). Since chronic disease is
a wide-encompassing term for a multitude of diseases, it is important to categorize them into
objective categories. Chronic inflammation, oxidative stress, and cardiovascular disease were
chosen as subheadings that were considered origins of chronic diseases.
According to the Center for Chronic Disease Control (Buttorff, Ruder, and Bauman,
2017), 60% of the 247.5 million adults living in the United States were inflicted with a
chronic disease. Statistically, this led to a staggering 7 out of 10 Americans dying from issues
complicated by a chronic disease. Within healthcare, $1.65 trillion was spent annually
treating patients with one or more chronic diseases, which accounted for more than 75% of
the $2.2 trillion that the U.S. spent on health care (Erdam, Prada, and Haffam, 2013). Even
with these astonishing statistics, chronic disease is a preventable epidemic that some say is
being neglected. According to (Horton, 2005):
“The reduction of chronic disease is not a Millennium Development Goal (MDG).
While the political fashions have embraced some diseases—HIV/AIDS, malaria, and
tuberculosis, in particular—many other common conditions remain marginal to the
mainstream of global action on health. Chronic diseases are among these neglected
conditions.” (p.1514)
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Statistically, chronic diseases are hurting the financial status of the US healthcare system and
leaving Americans with a 70% chance of dying from complications.
Implementing an intervention plan to reduce the impact of chronic diseases could
have multiple positive impacts on society. The keys to any intervention are prevention and
reduction of any negative health consequences (Partnership to Fight Chronic Disease, 2007).
Risk of chronic diseases may be reduced by lifestyle modifications and early detection. The
CDC reported that the leading determinants of chronic disease risk derived from a lack of
exercise, poor nutrition, and tobacco/alcohol use, all of which are relatively modifiable
(“Power of Prevention,” 2009). Thus, regulations of modifiable risk factors have been
identified as key in chronic disease prevention strategies (CDC, 2009).
The most common approaches to modifying chronic disease risk factors involve
instruction to stop the causes at the source such as: reduce or abstain from alcohol
consumption, cease tobacco products, monitor caloric consumption with an eye toward
energy balance (Willett et al. 2006). Success at adopting these lifestyle interventions has
been limited (Abramson, 2005). Abramson (2005) stated that people failed in their exercise
and diet protocol because of their lack of understanding of the different niches of fitness and
nutrition such as the financial and time commitments of gym memberships, nutritional plans,
meticulous cooking, and shopping for healthy foods (Roa, et al, 2013).
For instance, many dieting fads have a start and end date; however, when considering
chronic diseases prevention, modifying risk factors has been shown to require less acute
approaches (Willett et al., 2006). Investigating attainable and sustainable lifestyle
interventions shown to have positive effects on the reduction of chronic disease is an
important and necessary endeavor (Abramson, 2005).
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Adopting a healthy diet, in conjunction with regular physical activity, has been shown
to improve health in humans (Coe, 2012). Feig and Lowe (2017) found that dietary
consistency and compliance was key to maintaining weight and remaining healthy. Lemstra
(2016) reported that finding a dietary plan that was easily adoptable and consistently
followed was a challenge.
Though consistency was identified as a challenge, Wegman and colleagues (2015)
found that an alternate-day fasting protocol was easily followed and dietary compliance was
only an issue when subjects were told to overeat. Intermittent fasting has been readily
adopted over the last ten years (Collier, 2013). Intermittent fasting has been shown to be
realistic, attainable, and sustainable solution to prevent modifiable risks of chronic diseases
(Lay, 2014). Varady and Hellerstein (2007) found that intermittent fasting not only helped
adults lose weight, but also helped decrease chronic disease risk through a myriad of
secondary health benefits.
Intermittent Fasting
In the past decade, interest in new popular dieting fads have steadily led the general
public toward intermittent fasting (Collier, 2013). (Research has shown intermittent fasting
works to reduce overall body mass and body fat percentage in overweight and obese adults,
as well as a way to maintain full-body health in active, nonobese adults, according to
Ganesan, Habboush, and Sultan (2018)). Intermittent fasting is an umbrella term for shortterm caloric restriction for periods shorter than 24 hours, which leaves room for different
protocols for participating in an intermittent fasting regimen (Patterson et al., 2015). There
are three main regimens of intermittent fasting for health benefits: complete alternate-day
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fasting (ADF), modified weekly fasting regimens (MIF), and time-restricted feeding (TRF;
Patterson et al., 2015).
Complete alternate-day fasting involves one day of zero caloric intake or energyproducing ingestion followed by another day of feeding ad libitum, or as willed (Varady &
Hellerstein, 2007). Modified weekly fasting regimens involve the popular 5:2 diet, which
involves caloric restriction by consuming only 20-25% of needed energy calories for two
consecutive days and then eating ad libitum for the other five days of the week (Patterson et
al., 2015). Finally, time-restricted feeding involves a lack of energy consumption for a
majority of each day (Patterson et al., 2015). For example, the 16:8 or 18:6 time-restricted
feeding protocol would involve neither eating nor consuming calories for 16-18 hours and
then eating ad libitum for 6-8 hours of the day.
According to Collier (2013), intermittent fasting is an anomaly when it comes to most
dietary plans because of its simple and straightforward constraints. Intermittent fasting plans
allow participants to consume the types of foods they like, unlike most diet plans. The only
difference between intermittent fasting and other diet plans is that participants are only
allowed to eat for a few select hours of the day or on select days of the week, while most diet
plans ask for the user to eat small meals all the time, reduce calorie intake, or eat special
meals.
Intermittent fasting works by decreasing the overall caloric consumption period in
one’s week, or by restricting the time an individual is allowing themselves to eat. By
reducing the consumption period, the non-consumption time is also increased. By reducing
the eating time, an individual reduces his or her caloric intake measured in kilocalories or
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calories consumed by an individual in a defined amount of time, measured in calories
consumed per day (Varady, Bhutani, Church, and Klemptel, 2009).
The majority of health benefits accrued from intermittent fasting originate from the
fasting period, which permits the body to predominately use stored fatty acids instead of
macronutrients the user is consuming (Byrne, Sainsbury, King, Hills, Wood, 2018). Not only
has this been shown to decrease excess body fat, but because fat is more difficult for the body
to consume than carbohydrates, the body burns more calories by consuming stored fat
(Hayward et al., 2014), This short-interval fat utilization method has had a significant impact
on weight loss and favorable body composition changes (Ganesan, Habboush, and Sultan,
2018). Increased stored fat utilization and weight loss aid are not the only benefits
intermittent fasting has been shown to produce. Intermittent fasting has been found to have
positive effects on inflammatory biomarkers, improved cardiovascular system efficiency,
increased insulin sensitivity, reduction in oxidative stress levels, as well as improvement in
the neurological system, the immune system and the lifespan (Collier, 2013).
Biomarkers.
Strimbu and Tavel (2010) defined a biomarker broadly as a biological sign, an
objective indication of a medical state that can be measured accurately and quantified from
outside of the patient. In terms of this review, biomarkers for inflammation included insulin,
leptin and TNF- (Tumor Necrosis Factor Alpha); F2-Isoprostanes and free radicals for the
investigation of oxidative stress; and resting heart rate, blood pressure, and cholesterol blood
levels for cardiovascular measures (Collier, 2013).
It is important to note that the effects of biomarkers have not been researched heavily
in humans. Mayeux (2004) stated that the reason for this lack of human research was related
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to the invasiveness of biomarker-testing in humans, causing ethical limitations to the studies.
Even though there is lack of research in this area, intermittent fasting has been used as a way
to reduce possibly harmful secondary biomarkers and improve beneficial secondary
biomarkers (Aly, 2014).
Intermittent fasting and oxidative stress. Oxidative stress, cellular inflammation,
and insufficient cardiac activity are additional factors identified to lead to chronic disease
(Khansari, Shakiba, and Mahmoudi, 2009). Roberts and Barnard (2005) found intermittent
fasting helped decrease oxidative stress and cellular inflammation, as well as improve the
health of the cardiovascular system. Oxidative stress derives from an imbalance in the ratio
between the input into chemically reactive oxygen-containing chemical species and the
output of these species by detoxifying and damage repairing tools, which occurs through the
antioxidant defense system (Burton and Jauniaux, 2011). Oxidative stress is suspected to be
linked to the development of neurodegenerative diseases, cardiovascular diseases, and even
cancer (Khansari, Shakiba, and Mahmoudi, 2009).
Free radicals. Free radicals are molecules that have an unpaired valence electron that
is unstable. Biologically, they result from metabolic processes and are regulated by the
antioxidant mechanisms. In excess, they can be harmful to the body and can cause various
diseases, including Parkinson’s disease, Schizophrenia, and Alzheimer’s (Collier, 2013). Free
radicals are not just dangerous by themselves, but can form other dangerous compounds,
isoprostanes (Milne, Yin, Hardy, Davies, and Roberts, 2011).
Isoprostanes are compounds formed in vivo from a reaction with free radicals. High
levels of isoprostanes are suspected to increase risk of myocardial infarction and have been
used as biomarkers for oxidative stress in research subjects (Montuschi, Barnes, and Roberts,
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2004). Free radicals have been found to be detrimental by increasing the risk of
neurodegenerative diseases and the risk of heart attacks (Montuschi, Barnes, and Roberts,
2004). Collier (2013) reported that even though free radical studies remain minimal, evidence
points to a reduction in free radicals throughout the body after a short-term bout of
intermittent fasting protocol.
Intermittent fasting and inflammation. Inflammation is a natural, biological
response to harmful stimuli and serves as the body’s protective reaction to damaged cells or
irritants (Johnson, Summer and Cutler, 2006). While beneficial in acute injuries, chronic
inflammation has been found to lead to a number of life-altering diseases, including cancer,
cardiovascular disease, neurodegenerative diseases, respiratory diseases, etc. (Kunnumakkara
et al, 2018).
Biological markers of inflammation include TNF- and leptin, as well as insulin
(Johnson, Summer and Cutler, 2006). Leptin is a naturally-occurring hormone produced by
adipose cells to help regulate energy balance in the body by inhibiting hunger. Leptin has
also been found to be involved in the regulation of the inflammatory response. Chronically
increased levels of leptin have been found to be associated with inflammatory-related
diseases (Mattson and Wan, 2015). TNF- (Tumor Necrosis Factor) is a cell-signaling
protein, activated by white blood cells called macrophages, that is involved in inflammation
in the body. While beneficial in acute inflammation, TNF- also plays a part in many
autoimmune disorders found to be related to chronic inflammation (Shojaie, Ghanbari,
Shojaie, 2017). Both leptin and TNF- have been used as biological markers of chronic
diseases and can be used to track the onset of a possible inflammatory-based chronic disease
(Shojaie, Ghanbari, Shojaie, 2017).
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Insulin resistance has been shown to cause an increase in chronic inflammation at a
cellular level (Khansari, Shakiba, and Mahmoudi, 2009). Insulin, a hormone naturallyoccurring in the body, is secreted by beta cells, found in the pancreas, in order to regulate the
metabolism of carbohydrates, fats, and proteins by increasing the use of carbohydrates as
energy (McArdle, Katch, and Katch, 2015).
Diabetes Mellitus Type 2, commonly referred to as Type 2 Diabetes, is a metabolic
disorder that involves the body’s increased insulin resistance, according to Kharroubi and
Darwish (2015). Type 2 diabetes has been found to result from an increase of insulin
resistance, which can be caused by obesity, lack of exercise, and genetic risks (Kharroubi and
Darwish, 2015). Obesity and a lack of exercise can increase the risk of developing type 2
diabetes, and certain genes can cause an increased risk of developing type 2 diabetes as well
(Kharroubi and Darwish, 2015). In most cases, Type 2 diabetes can be managed by lowering
cardiovascular risk factors, losing weight, exercising, and maintaining normal blood glucose
levels (Mitchell, Catenaci, Wyatt, and Hill, 2011).
Insulin sensitivity, TNF-, and leptin have been investigated in relation to
intermittent fasting (Sutton et al., 2018). Because of intermittent fasting’s proposed chronic
anti-inflammatory effects, there is evidence that intermittent fasting may lead to a decrease in
these inflammatory biomarkers, therefore improving chronic cellular inflammation chronic
diseases (Shojaie, Ghanbari, and Shojaie, 2017).
Intermittent fasting and the cardiovascular system. The cardiovascular system,
comprised of the heart, blood vessels, and its contained blood, is the organ system of the
body that allows blood to circulate and transport nutrients, hormones, and blood cells
carrying oxygen and carbon dioxide. Cardiovascular system variables include resting blood
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pressure and heart rate, as well as total cholesterol levels (Varady, Bhutani, Church, and
Klemptel, 2009). Heart rate is measured in beats of the heart per minute (McArdle, Katch,
and Katch, 2015). Blood pressure is the pressure of circulating blood on the walls of arterial
and venous blood vessels (McArdle, Katch, and Katch, 2015). It is measured in millimeters
of mercury above the surrounding atmospheric pressure and is comprised of systolic and
diastolic blood pressure. Systolic blood pressure is the maximum pressure during one
heartbeat, while diastolic blood pressure is the minimum pressure between two heart beats. A
normal resting blood pressure is usually a 120 mmHg systolic pressure over a 80 mmHg
diastolic pressure (McArdle, Katch, and Katch, 2015). A heightened blood pressure and heart
rate suggest a heart that is working harder than it needs to because of an underlying issue,
according to McArdle, Katch, and Katch (2015).
In addition to the concerns raised with an unhealthy blood pressure and heart rate,
cholesterol, a fatty substance that is found in the blood, can also be problematic if levels rise.
Cholesterol is an organic molecule characterized by a waxy-like texture that is found
naturally in the body (Varaday, Bhutani, Church, and Klempel, 2009). It is vital to the body
to make and maintain membranes in the body; however, excess amounts of cholesterol can
lead to heart attacks, stroke, or various vascular diseases (Varaday et al., 2009). Low-density
lipoproteins (LDL) and high-density lipoproteins (HDL) are two common biomarkers found
in health studies. LDL is sometimes referred to as the “bad type” of cholesterol because an
increased level of LDL can lead to a buildup of cholesterol in arterial walls, leading to heart
attacks and stroke (Varaday et al., 2009).
Heightened heart rate, blood pressure, and cholesterol levels generally means there is
something wrong going on in the body. In order to combat these issues, health professionals
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recommend exercise and special dieting plans when encountering these issues in patients,
according to the American Heart Association. Although these instructions are helpful and
have been proven to aid in cholesterol levels, resting heart rate, and blood pressure levels,
there are hypotheses about whether or not intermittent fasting could play a major role in
helping reduce these cardiovascular biological markers even without the aid of exercise
(Francis, Young, and Lara, 2017).
Purpose
The purpose of this review was to explore the biological effects of intermittent fasting
in human adults, beside the effect on weight, that can lead to chronic disease. This systematic
review also worked to explore the effects of intermittent fasting on chronic disease
biomarkers in patients who already had been previously diagnosed. This systematic review
synthesizes completed research on intermittent fasting, effects on the cardiovascular system
(heart rate, blood pressure, cholesterol levels), inflammation (leptin and TNF-), and
oxidative stress biomarkers (f2-isoprostanes and free radicals). While intermittent fasting is
theorized to cause weight loss by a combination of reduced caloric intake and burning of
stored body fat, it has led to benefits like an increase in insulin and leptin sensitivity, as well
as a decrease in cholesterol levels, inflammation, free radicals, and resting blood pressure and
heart rate.
This review evaluated the clinical evidence that fasting is beneficial in humans.
Clinical evidence has involved randomized controlled trials of the effects of fasting on
relevant surrogate outcomes (e.g. cholesterol, inflammatory biomarkers, etc.) as well as the
actual clinical endpoints (e.g. diabetes, cardiovascular disease, etc.) and any other studies of
other supporting clinical outcomes. In addition, this study will include and discuss results
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taken from animal studies to use as supporting evidence; however, no conclusive remarks
will be made based on them.
Methods
The review of participating studies followed a systematic procedure, which included
particular inclusion criteria during searches and data extraction. The primary aim of these
searches were to 1) identify randomized clinical trials of intermittent fasting in which a
standard diet or control group was used, 2) find studies that tested for the listed biomarkers in
humans, and 3) find studies that observed the desired clinical endpoints in humans. Searches
were also used to analyze animal studies meeting this criteria, in areas with little research.
Inclusion and Exclusion Criteria
Study designs included in this review were both human and animal clinical trials,
with emphasis on use of human trials. These trials were randomized controlled trials and
pilot studies. Original research studies and review articles were included, but case studies,
surveys, and abstracts were excluded from review. To be included for this review, studies
had to use human subjects of any age or BMI that would undergo an intermittent fasting or
alternate-day feeding protocol. Studies researching Ramadan fasting were excluded because
of their differing eating patterns from standard intermittent fasting protocols. Studies that did
and did not include a control or comparable group were included to give a broader
perspective of intermittent fasting research; however, studies with control groups were
primarily used for data analysis.
No limit was placed on the duration of the intermittent fasting of subjects. Studies
were excluded if participants were taking medication designed to induce weight loss or
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reduce blood pressure, if participants were on a given diet (not ad libitum feeding), were
diagnosed with cancer, were adolescent, elderly, or pregnant.
To be included for this systematic review, studies needed to measure one or more
variables prior to the commencement of the intermittent fasting diet and following the
cessation of the intermittent fasting period that the study investigated. Studies investigating
parameters during the course of the intermittent fast program were favored.
Search Strategy
A systematic review of the literature was conducted by searching computerized
databases for scholarly, peer-reviewed articles that had been published between January 1998
and December 2018, with limitations to the English language. Computerized data bases that
were used included Bulldog One Search, found through the Gardner-Webb Library home
page, Google Scholar, and PubMed/MEDLINE. Search engine requests included the terms,
“Intermittent fasting”, “energy restriction,” and “caloric restriction,” when researching
intermittent fasting studies; “Inflammation,” “oxidative stress,” and “cardiovascular system,”
as well as their sub-terms: “blood pressure,” “heart rate,” “leptin,” “TNF-,” “Insulin,”
“isoprostanes,” and “free radicals” were used to research the affected variables in studies. In
addition, the reference list of articles found in the search articles were examined for other
trials and studies to ensure that all relevant studies were found.
Multiple searches were conducted with variations of the searched phrases, which
included one of the primary “intermittent fasting” phrases and at least one of the sub-terms
listed above.
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Data Analysis
The titles and abstracts of the studies identified through use of the search strategy
were screened prior to data analysis to ensure that they met the inclusion criteria. The full
texts of the approved relevant studies were retried and then screened again with a full read
through, analyzing the inclusion and exclusion criteria. Studies discussed in the investigated
research articles that were possibly relevant to this review were investigated and prepared
according to this same system. If the studies did not abide by the inclusion/exclusion criteria,
they were discarded.
Results
Search Results and Study Characteristics
After a thorough search of the search engines, a total of 343 studies were found to be
relevant towards the objectives of this review. Of these 343 studies, abstracts of these were
read and analyzed. Thirteen were found fit, after reviewing inclusion and exclusion criteria,
to be discussed in this review. A total of thirteen studies were included in this review, with
eight of the studies pertaining to inflammatory biomarkers, three of the studies examining
oxidative stress biomarkers, and eight of the studies examining cardiovascular chronic
disease biomarkers. Of these 13 studies, seven of them used human subjects, while two of
them used rats as subjects, and four were review studies looking at both human and animal
trials. The intermittent fasting regimens varied across studies, with some including alternate
day feeding (ADF), some modified weekly fasting (MIF), and some time-restricted feeding
(TRF). Intermittent fasting regimen durations ranged from three weeks to twelve weeks.
Study characteristics for studies with human subjects were identified and organized in Table
1, while animal subject study characteristics were identified in Table 2.

18

INTERMITTENT FASTING EFFECTS ON CHRONIC DISEASE

Table 1. Study Characteristics of Intermittent Fasting Studies with Human Subjects
Author/Year
IF
Study
Number of
Studied
Mean age
Mean
Protocol Duration Participants
variables
per group weight per
(weeks)
(years)
group (kg)
Bhutani et
ADF
12
64
LDL, HDL,
45
93
al., 2013
total
cholesterol,
HR, SBP,
DBP, insulin
Harvie et
MIF (2:5)
26
107
Oxidative
40
81.5
al., 2011
stress, leptin,
TNF-,
isoprostanes,
HR, SBP,
DBP, LDL,
HDL, insulin
sensitivity
Heilbronn et
ADF
3
16
BP, LDL,
34, 32
59.7, 80.6
al., 2005
HDL, insulin
sensitivity
Johnson et
ADCR
8
9
N/A
105
TNF-, LDL,
al., 2007
HDL
Sutton et al.,
2018

TRF
(18:6)

5

22

Varady et
al., 2009

ADF

12

30

Oxidative
stress, HR,
BP, insulin
sensitivity

36

Not
measured

HR, LDL,
47
77, 77
HDL, Total
Cholesterol
Wegman et
ADF
10
24
Oxidative
24
Not
al., 2015
stress, plasma
measured
Insulin
Notes. IF- intermittent fasting, ADCR- alternate day caloric restriction, TNF-- Tumor
Necrosis Factor , SBP- systolic blood pressure, DBP- diastolic blood pressure, kgkilograms, HDL- High-density lipoprotein cholesterol, LDL- low-density lipoprotein
cholesterol
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Table 2. Study Characteristics of Intermittent Fasting Studies with Animal Subjects
Author/Year
IF
Study
Type/
Studied
Mean age
Mean
Protocol Duration number of
variables
(months)
weight
(weeks)
animal
(grams)
subjects
Ahmet et
ADF
12
SpragueHR,
2
66
al., 2005
Dawley/
inflammation
n=60
Wan et al.,
2010

ADF

12

Male
Inflammation,
Wistar/
Insulin, BP
n=30
Notes. ADF- alternate day feeding, HR- heart rate, BP- blood pressure

2.5

460

The review articles that were included in the review discussed studies that
investigated the effects of intermittent fasting on chronic disease risk factors and the
implications behind the results of these studies. Of the four review articles, none of them
followed systematic review guidelines, but all four of them were found to withstand the
inclusion criteria for this study.
Study Outcomes
Each study was reviewed to clarify and confirm or deny implications of previous
research on intermittent fasting affects risk factors for developing chronic disease in adults.
Study Outcomes of Human Trials.
A controlled randomized trial study investigating the effects of an intermittent fasting
diet and exercise on plasma lipids in obese humans was conducted by Bhutani, Klempel,
Kroeger, Trepanowski, Varady (2013). The study examined 64 obese subjects that were
randomly selected to one of four groups: combination of alternate day fasting (ADF) and
endurance exercise, ADF only, exercise only, and control. ADF subjects were instructed to
eat ad libitum every other day, followed by a fasting day of 25% of their normal daily caloric
intake on a 3-day rotating menu plan provided. After 12-weeks of following the dieting
protocol, total cholesterol and LDL cholesterol was reduced in the ADF and combination
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intervention groups (12 ± 5%, P < 0.05), while HDL cholesterol increased (18 ± 9%, P <
0.05). These findings concluded that the combination of intermittent fasting and endurance
exercise produce superior changes in lipid indicators of heart disease risk.
Heilbronn et al. (2005) investigated the effects of a short-term intermittent fasting
dieting regimen on body weight and biomarkers of longevity in nonobese subjects. Sixteen
healthy subjects were recruited and instructed to fast intermittently for three weeks with one
day eating ad libitum, followed by a day of a complete fast, following a strict alternate-day
feeding protocol (ADFP). A fasting blood sample and blood pressure were taken at baseline,
throughout, and after the cessation of the dieting period. Results showed a decrease in fasting
insulin of 57 ± 4% (P < 0.001) and insulin was reduced after fasting days, suggesting an
improved insulin sensitivity; however, fasting insulin did not drastically decrease following a
12-hour fast. In addition, systolic and diastolic blood pressure were not significantly reduced
by the intermittent fasting intervention. It was noted that this study’s design may have
affected results because of a lack of dietary adherence from subjects. It was concluded that
the intermittent fasting protocol did slightly increase insulin sensitivity, which could help
improve benefits of chronic disease; however, these results were inconclusive.
In addition, Johnson et al. (2006) conducted an eight-week study to investigate the
effects of ADCR on markers of oxidative stress and inflammation in overweight adults with
moderate asthma. The subjects (n=10) were instructed to eat ad libitum (at one’s desire) for
one day, followed by a day of consuming less than 20% of their normal caloric intake. Blood
was collected throughout the study in order to measure markers of oxidative stress and
inflammation. Results indicated a reduction of all levels of leptin, serum cholesterol, TNF-,
and markers of oxidative stress (isoprostanes). The improved clinical findings demonstrated
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rapid and beneficial effects of an intermittent fasting protocol, suggesting a new approach for
therapeutic intervention for those with asthma.
With a discussion about the effects of intermittent fasting on all three of the chronic
disease risk factors reviewed, Sutton et al. (2018) presented a study that investigated the
effects of time-restricted feeding (TRF) on insulin sensitivity, blood pressure, and oxidative
stress in men with Prediabetes. In this study, 22 men were separated into two groups, a time
restricted feeding protocol group, eating for six hours and fasting for 18 hours of each day,
and a control group, that ate and fasted for 12 hours each day. The subjects remained on this
diet regimen for five weeks before they changed diet protocols. Throughout and after
cessation of the study, blood samples and blood pressure were taken for each subject. They
found that subjects following the TRF protocol had an increased insulin sensitivity as well as
decreased blood pressure and oxidative stress levels. It was concluded that, because of the
results being independent of weight loss, intermittent fasting could improve aspects of
cardiometabolic health.
In addition to the findings on chronic disease risk markers, a study by Harvie et al.
(2010) researched the effects of both an intermittent and continuous energy restriction
protocol on weight loss and chronic disease risk biomarkers in young overweight women.
107 subjects with an average age of 40 were separated into two different groups: an
intermittent energy restriction and continuous energy restriction group. The intermittent
fasting group followed two days of eating 75% of their normal daily caloric intake, followed
by five days of eating according to a nutrient composition Mediterranean-type diet. The
continuous energy restriction group followed the Mediterranean-type diet for seven days of
the week. The study lasted 6 months (26 weeks) and blood samples were taken at the end of
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the first, third, and sixth month of the diet. Results showed similar weight loss in both
groups, a modest decrease in fasting insulin in both groups, however, improvements in
insulin sensitivity were greater in the intermittent fasting group. Both groups showed a
modest reduction in oxidative stress biomarkers, inflammatory biomarker Leptin, LDL
cholesterol, total cholesterol, and systolic blood pressure. Limitations were listed as the
short-term length of the study and the lack of inclusion of local changes, like food
substitutions or environmental/stress changes, that could have occurred.
Varady et al. (2009) investigated the effects of short-term modified alternate day
fasting (ADF) on weight loss and cardioprotection. Sixteen obese subjects (twelve women
and four men) completed a 10-week ADF protocol, which followed a two-week control
phase, four-week ADF controlled phase, and four-week self-selected ADF phase. Blood
samples were taken after a 12-hour fasting at the end of each phase. As a product of the 10week study, dietary adherence remained relatively high (86%), resulting in a decrease of
mean body weight of subjects (5.6 ± 1.1%), total cholesterol (21 ± 4%) and LDL
cholesterol levels (25 ± 10%), and systolic blood pressure (from 124 ± 5 to 116 ±
3 mm Hg). Findings suggested that an ADF diet could help obese individuals reduce weight
and decrease coronary artery disease risk.
A 10-week double crossover study, completed by Wegman et al. (2015), investigated
the effects of an intermittent fasting regimen on oxidative stress and gene expressions. This
study completed a 10-week long regimen of alternate day caloric restriction (ADCR), in
which subjects alternated a day of eating 175% of normal daily caloric intake, followed the
next day by 25% of their normal daily caloric intake. The subjects were told to report their
level of comfort and adherence to the diet throughout. This study found that when subjects
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strictly adhered to the intermittent fasting protocol, there was no change of oxidative stress
markers, and there was a decreased level of plasma insulin levels. This study suggests that an
intermittent fasting dieting paradigm is acceptable in healthy individuals, but further research
would need to be conducted to further assess risks and benefits.
Of these previously stated scholarly articles, the resulting effects of intermittently
fasting groups are listed in Table 3 and sectioned between their effects of each chronic
disease risk factor.
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Table 3. Effects of Intermittent Fasting on Chronic Disease Risk Factors in Human Studies
Study
Cardiovascular
Oxidative Stress
Inflammatory
Effects
Effects
Effects
Bhutani et al.,
Not measured
LDL:  (-12 ± 5%)
Insulin: 
2013
(-21 ± 15%)
HDL:  (18 ± 9%)
Total Cholesterol:
unchanged
HR: unchanged
SBP:  (-3 ± 1%)
DBP:  (-2 ± 2%)
Harvie et al.,
LDL:  (-9.7 %)
Oxidative Stress: 
Leptin:  (-40.1%)
2011
HDL: unchanged
TNF-:  (-2.1%)
SBP:  (-3.7 mm Hg)
Insulin: 
DBP:  (-4.3 mm Hg)
(-2.1 U/mL)
Heilbronn et al., BP: unchanged
Not measured
Insulin sensitivity: 
2005
LDL: 
HDL: 
Johnson et al.,
Not measured
LDL: 
TNF-: 
2007
(-10.5 ± 8.9%)
HDL:  (4.1 ± 1.3%)
Sutton et al.,
HR: 
Oxidative Stress: 
Insulin sensitivity: 
2018
BP: 
Varady et al.,
Not measured
Not measured
LDL: 
2009
(26.0 ± 8.2%)
HDL: Unchanged
Total Cholesterol: 
(-18.0 ± 4.3%)
SBP:
(4.4 ± 1.8%)
HR: 
Wegman et al., Not measured
Oxidative Stress:
Plasma Insulin: 
2015
Unchanged
(-1.01 U/mL)
Notes. IF- Intermittent fasting, SBP- systolic blood pressure, HR- heart rate
Study Outcomes of Animal Trials
In a 12-week study, Ahmet, Wan, Mattson, Lakatta, Talan (2005) investigated the
effects of an intermittent fasting diet on two-month-old rats. The intermittent fasting protocol
included an alternate-day feeding intermittent fasting protocol with a standard rat diet ad
libitum on eating days. After three months of dieting, an electrocardiogram (EKG) was
conducted prior to and post a coronary artery ligation, causing a myocardial infarction. The
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study found that 24-hours after the induced MI, rats in the intermittent fasting group had a
significantly reduced MI, inflammatory response, and apoptotic myocytes when compared to
the control group. An electrocardiography was performed on surviving rats 10 weeks after
the induced MI, with a continued intermittent fasting regimen, and found that there was less
left ventricular remodeling, better left ventricular function, and no MI expansion in the
intermittent fasting group compared to the control group of rats. It concluded that intermittent
fasting could protect the heart from ischemic injury and aids in anti-inflammatory
mechanisms.
In addition, Wan et al. (2010) conducted another study, which looked at the cardio
protective effects of intermittent fasting in rats after an induced MI and stroke. This study
utilized 30 two-and-a-half month-old male Wistar rats that were maintained for one month
prior to initiation of dietary protocol. The rats were separated into either an ad libitum or
intermittent fasting diet, following a 12-week protocol. At the beginning, during, and near the
end of the study, blood samples were taken. At the end of the 12 weeks, the rats had a
myocardial infarction induced by a coronary artery ligation surgery. Following the ligation,
permanent ligation of the coronary artery and markers of inflammation were significantly
smaller in rats following the intermittent fasting diet protocol. In addition, insulin levels were
significantly lower in the rats following the intermittent fasting diet than the ones following
the ad libitum diet. It concluded that these results suggest an intermittently fasted diet could
improve cardiovascular health and cardio protective elements compared to an ad libitum diet.
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Table 4. Effects of Intermittent Fasting on Chronic Disease Risk Factors in Animal Studies
Study
Cardiovascular
Oxidative Stress
Inflammatory
Effects
Effects
Effects
Ahmet et al.,
Not measured
HR: 
Inflammation: 
2005
Not measured
HR: 
Inflammation: 
Wan et al., 2010
(-18%)
Plasma Insulin: 
Notes. IF- intermittent fasting
Study Outcomes of Review Articles
In addition to the clinical findings of animal and human studies, four reviews were
analyzed to understand the effects of intermittent fasting on chronic disease risk factors.
A review study by Mattson, Longo, and Harvie (2017) analyzed intermittent fasting
studies to determine whether or not previous research verifies the efficacy of intermittent
fasting in improving general health, and prevention and management of chronic diseases.
Mattson found that with studies in animals, there were profound general health benefits for
laboratory rats and mice. The studied articles showed animal subjects improving functional
outcomes and counteracting disease processes, such as cardiovascular disease, diabetes,
cancer, and some neurological disorders. In human trials, health benefits were just as
beneficial. Human subjects completing a short-term intermittent fasting protocol were found
to have improvements in many health indicators, including insulin sensitivity and reduction
in risk factors for cardiovascular disease.
In a study by Varady and Hellerstein (2007) both human and animal studies were
analyzed to determine if chronic disease prevention is possible from following a caloric
restricted or alternate-day fasting regimen. This review looked at 15 studies that investigated
the health benefits of intermittent fasting. Consistently reduced insulin concentrations,
reduced resting heart rate and blood pressure, and lowered LDL and total cholesterol levels
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were all reported in rats following an alternate-day feeding protocol. In human trials, shortterm alternate-day feeding protocols resulted in inconsistent results for insulin sensitivity,
blood pressure, and inflammatory effects; however, limitations to these research studies
include a limited intervention period. It concluded that alternate-day fasting may effectively
result in decreased risk factors of cardiovascular disease and increases of resistance to
oxidative stress, which could result in a decreased risk of chronic disease.
In addition, another review performed by Mattson and Wan (2005) investigated the
effects of intermittent fasting on the cardiovascular and cerebrovascular systems. Similarly,
this review found evidence of decreased resting heart rate, blood pressure, insulin resistance,
LDL and total cholesterol levels in addition to a reduction in circulating levels of TNF- in
laboratory rats and mice. In reviewed human studies, there were similar results with obese or
overweight subjects. A reduction in inflammation, oxidative stress, heart rate, blood pressure,
and LDL and total cholesterol levels were all reported. However, the study stated that there
was little research that investigated the same effects of intermittent fasting in humans with a
healthy weight.
Lastly, a study conducted by Ganesan, Habboush, and Sultan (2018) examined the
effects of intermittent fasting in four randomized controlled studies using adult, human
subjects. This review looked at studies that investigated the effects of an alternate day fasting
protocol on weight loss and other biomarkers. It was found that short-term use of alternateday fasting resulted in weight loss across the board as well as reductions in LDL, total
cholesterol, and systolic blood pressure. The review also found a decrease in insulin
resistance in two of the four studies. In regards to the review’s limitations, it concluded that
this review was limited to English-speaking adults and obese individuals. Future research
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should include evidence on how intermittent fasting could help improve biomarkers in
healthy individuals.
Discussion
After a systematic review of the 13 studies, the synthesis of the collected data
determined that various intermittent fasting protocols were effective in reducing caloric
intake and body weight. In addition, there was evidence supporting the idea that intermittent
fasting could reduce chronic disease risk markers in human and animal subjects; however,
there were other plausible reasons for the improvements of chronic disease risk markers.
Main Findings
A systematic review of the 13 studies showed that intermittent fasting can play a role
in decreasing chronic disease risk factors biomarkers. Yet, there was noticeable variability in
the reviewed studies that needs to be taken into consideration. Of the nine reviewed studies
with both animal and human subjects, the hypothesis was borne out by decreases in LDL
concentrations, systolic blood pressure, diastolic blood pressure, heart rate, oxidative stress,
TNF-, and insulin, and the hypothesis was borne out by increases in HDL concentrations
and insulin sensitivity for majority of the human studies. These findings support the claim
that intermittent fasting can help decrease risk factors for chronic disease.
Human subjects who were previously diagnosed with a chronic disease showed more
drastic improvements of chronic disease risk factors after completing a short-term
intermittent fasting regimen than healthy human subjects. With that information, it can be
implied that intermittent fasting regimens can be used to reduce risk factors of those who are
already diagnosed. Even though it cannot be inferred that intermittent fasting regimens could
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treat chronic diseases, statistical improvements of chronic disease risk factors are a step
forward for these individuals.
After review of the general main findings, results and implications of each of the
chronic disease risk factors are reviewed and stated below.
Oxidative stress. Among the studies investigating the impact of intermittent fasting
on oxidative stress, there was supporting evidence that intermittent fasting could decrease
oxidative stress in subjects. In studies run by Sutton et al. (2018) and Harvie et al. (2009),
oxidative stress decreased following a five month and 26-month stent of alternate day fasting.
The reviewed studies found that following an intermittent fasting diet could improve
oxidative stress resistance and decrease oxidative stress because of the oxidative stress
hypothesis and stress resistance hypothesis (Mattson and Wan, 2005). The oxidative stress
hypothesis states that because intermittent fasting protocols cause a reduction in caloric
intake, there is less means for the production of free radicals in the mitochondria of the cells.
However, this implies that caloric restriction diets would cause the same effect on oxidative
stress. On the other hand, the stress resistance hypothesis explains that because of the
extended periods of fasting, which causes stress, the body is able to resist the stress of fasting
better. This stress resistance can be associated with an increased cellular resistance to
oxidative injury. It implied that because of this improved stress resistance from intermittently
fasting and restricting caloric intake, the body becomes more immune to stressors and is
therefore better prepared to combat chronic disease risk factors and possibly prolong life.
In addition to these two hypotheses, another theory, called the induction of scarcity
program hypothesis, explains the decrease in oxidative stress following an intermittent
fasting protocol (Varady and Hellerstein, 2007). This hypothesis explains that when one
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utilizes an energy restricting diet, cellular and metabolic programs react with the intermittent
scarcity of energy consumption, causing a decrease in metabolic processes that contribute to
the degradation of cells.
While all three of these theories could explain the induced deficit of measured
oxidative stress, evidence for these theories are minimal and only present in trials using
rodents and cellular subjects, like yeast. A more extensive exploration of these effects from
an intermittent fasting regimen could create improved insight on its effects.
Inflammation.
In both human and animal subjects, the reviewed articles found that inflammatory
effects from following an intermittent fasting diet have the potential to be positive. Of the
seven reviewed clinical trials with human subjects, six of the studies tested for inflammatory
biomarkers, including plasma insulin, insulin sensitivity, and TNF-. A decrease in plasma
insulin, leptin, TNF-, with an increase in insulin sensitivity was discovered in Sutton et al.
(2018). These decreases in inflammation biomarkers in humans can be inferred to help
prevent and combat inflammation found in chronic diseases, like diabetes, cardiovascular
disease, chronic neurodegenerative diseases, and autoimmune diseases.
The decrease in plasma insulin and the improvement in insulin sensitivity, prevalent
in six of the seven human trials, has been shown to cause a reduction in Type-2 diabetes risk
(Varady and Hellerstein, 2007). The reasoning for this correlation is based on the increase of
fat oxidation during fasting periods of an intermittent fasting protocol, which causes a
reduction of intracellular lipid accumulation. For individuals struggling with Prediabetes or
diagnosed Type-2 diabetes, intermittent fasting could be a possible health-improving
implementation. To add on, leptin, which has been found to lead to insulin resistance and
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even breast cancer risk, was also reduced during the one reporting human study (Harvie et
al., 2011). This decrease, as stated by Harvie et al. (2011), could have aided in the decrease
of plasma insulin and increase in insulin sensitivity, therefore improving the inflammatory
response.
In addition, a decrease in TNF- found in the reviewed human trials point to a
decreased risk of inflammation-based chronic diseases. The two human trials reporting TNF concentrations discussed that because of TNF-’s previous correlation to suppression of
inflammation, a reduction of TNF- could improve asthmatic symptoms and inflammatory
risk factors found in cardiovascular disease, rheumatoid arthritis, and autoimmune diseases
(Johnson et al., 2007). Again, this evidence supports intermittent fasting as a potential health
implementation for reducing the risk of inflammation-based chronic diseases.
Furthermore, animal studies showed a reduced inflammatory response to cardiac
injury by artificial ligation. Ahmet et al. (2005) and Wan et al. (2010) showed a decrease in
inflammatory cells within the hearts of surviving rodents 24-hours after a medically-induced
ischemic stroke, following six weeks of an alternate day fasting protocol. This evidence
suggests that an intermittent fasting diet could help promote cardioprotective effects even
prior to a cardiovascular injury. These results can translate to inflammatory-based chronic
diseases, as well.
Examined review articles point to a decrease in inflammation after a short regimen of
intermittent fasting, causing a decreased risk of cardiovascular disease, a decreased risk of
diabetes, and possibly a decrease in certain cancer risks. These results point to an effective
improvement of chronic disease risk factors in animals and humans; however, human studies
have been equivocal in their determination of direct causation. Because of a lack of objective,
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thorough evidence, results pointing toward a reduction in chronic inflammatory diseases
cannot be conclusive in human subjects.
Cardiovascular system.
The main findings affecting the cardiovascular system include a lowered heart rate,
systolic and diastolic blood pressure, and LDL cholesterol concentration. HDL cholesterol
concentrations were found to be raised after a bout of intermittent fasting, while total
cholesterol levels were found to decrease or remain the same in human subjects.
The cardiovascular effects were analyzed in the four reviews investigated. These
cardiovascular effects include the increase of HDL cholesterol and the reduction of resting
heart rate, blood pressure, LDL cholesterol, and total cholesterol concentrations. The
reductions of resting heart rate and blood pressure were found to be significant in animal
trials. It was found that within animal studies, cardiovascular systems of rats and mice
responded to an intermittent fasting treatment similar to the way it responds to aerobic
exercise (Mattson, Longo, Harvie, 2017). The relationship between intermittent fasting and
its effects similar to those of aerobic-exercise seems compelling enough to state that because
of the induced stress of caloric restriction, there is an improvement of health markers.
Resting heart rate and blood pressure reduced significantly within the first few weeks
of intermittent fasting and then remain reduced while following an alternate-day feeding
protocol. However, these reductions only remained temporarily after the cessation of an
intermittent fasting diet, proving that cardiovascular benefits are not sustained much after the
end of an intermittent fasting period. So, it implies that intermittent fasting can be used to
improve one’s aerobic baseline prior to the beginning of an aerobic exercise protocol. This
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comparison has not been researched or evident in human trials, so it cannot be concluded that
intermittent fasting could serve as a substitute for physical exercise early in human subjects.
Furthermore, total and LDL cholesterol concentrations following an intermittent
fasting period were reduced in both human and animal trials. These reductions, more
prominent in previously overweight or obese subjects, can correlate to the reduction in body
mass and may not be direct effects from following an intermittent fasting diet. However,
these reductions can be expected to decrease the risk of cardiovascular disease and stroke,
whether it was from direct effects of the intermittent fasting diet or from the reduction in
body mass. Studies following the effects in healthy individuals showed only modest
improvements of cholesterol levels, showing that plasma cholesterol levels may not be a
major consequence of intermittent fasting.
With these results in mind, it can be concluded that following an intermittent fasting
protocol can lead to a modest reduction in resting heart rate, blood pressure, and cholesterol
concentrations in healthy, human subjects. These moderate effects improve the overall
cardiovascular function and resilience in combatting ischemic injury, prevalent in stroke and
heart attacks. It infers that because of these improved biological markers, intermittent fasting
has the potential to be a legitimate procedure to follow in order to improve cardiovascular
health in overweight or obese individuals prior to the beginning of an exercise protocol.
In the future, while research on intermittent fasting points to the improvement of
overall cardiovascular health, more extensive research needs to be expanded in order to
understand the direct and indirect effects of intermittent fasting on cardiovascular health.
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Limitations
While this study followed an extensive systematic procedure of review, there are
limitations that exist. Because of intermittent fasting’s recent popularity, there are few studies
that are conclusive on the health benefits of this dieting protocol.
In addition, the lack of longitudinal studies on intermittent fasting leaves one
questioning the long term effects of the dieting protocol. While short-term intermittent
fasting studies show an improvement in chronic disease risk markers, there could be negative
effects of intermittent fasting in the long run, although these are not heavily researched.
Intermittent fasting studies showed improvements in chronic disease risk markers, yet
these improvements were much more drastic in previously diagnosed chronic disease patients
and obese or overweight subjects. Because of this, it infers that intermittent fasting does not
directly cause these improvements in chronic disease risk factors, but is indirectly involved in
the decrease of these biomarkers because of a decrease in body weight. Weight loss has been
shown to improve overall health, which could cause the decrease in these investigated
biomarkers. It is important to consider though that intermittent fasting does, in fact, lead to
weight loss.
While this study thoroughly investigated the reviewed articles, there were only ten
short-term clinical trials studied, which only used a limited number of participants. The
number of human subjects ranged from nine to 107 subjects, with an average of 39 subjects
per study. While this amount of participants is beneficial, it is hardly conclusive for the
general population.
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Implications
After assessment and consideration of the results from the reviewed studies, further
testing of intermittent fasting is needed. While animal studies of intermittent fasting
protocols show a clear, positive effect of intermittent fasting on cardiovascular biological
markers, other chronic disease risk factors are not as clearly defined. Of the seven clinical
studies with human subjects, only three of these studies discussed the oxidative stress effects
from following a short-term bout of intermittent fasting. Within these studies, biological
markers were used but were not thoroughly discussed and implications were minimal.
Research discussing more in-depth analyses with broader implications is needed in order to
establish the beneficial effects of intermittent fasting on the general population, for
combatting chronic illnesses.
In the future, intermittent fasting studies should include longer implementation
periods for subjects to partake in a larger, more diverse subject population, and a more
controlled environment. Additionally, discovered data should be analyzed more in depth in
order to correlate weight loss and secondary effects after following an intermittent fasting
protocol. A better understanding of how intermittent fasting effects each of the risk factors of
chronic disease needs to be analyzed.
But these health implications are relatively positive and reveal improvement of
chronic disease risk factors. None of the 13 reviewed articles discussed an increase of health
risk following an intermittent fasting protocol in either human or animal trials.
With all things considered, it can be inferred that following an intermittent fasting
protocol can positively improve the overall wellness of overweight or healthy humans and
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decrease the risk of contracting a chronic illness and reduce the impact it has on one’s quality
of life.
Conclusion
In conclusion, all 13 of the reviewed studies point to an improvement in biological
markers relating to cardiovascular stress, oxidative stress, and inflammation, all of which can
lead to major chronic diseases. These biological markers were found to be improved after a
short-term regimen of intermittent fasting; however, the studies were found to be more
beneficial for animal subjects than human subjects. Human studies found a relatively positive
interpretation of results, but, the effects on the reviewed risk markers were not consistent
throughout and therefore were not conclusive on whether intermittent fasting could directly
correlate to an improvement in chronic disease. Limitations of this review include the partial
amount of studies reviewed, the short-term duration of the clinical studies, the contamination
of weight loss and prior chronic disease diagnoses in subjects, and the inability to track
subjects’ dietary choices during the intermittent fasting protocol. In the future, research
should include long-term longitudinal studies of a greater subject population that investigate
the ability for life-long intermittent fasting to prevent chronic disease. Clinically, it is
concluded that intermittent fasting can be beneficial in the improvement of chronic disease
risk markers, but more research needs to be conducted in order to produce conclusive results.
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